Nuvilex Finalizes Asset Purchase Agreement and Completes Acquisition of SG Austria Assets

Published: Jun 28, 2012

SILVER SPRING, Md., June 28, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a biotechnology provider of cell and gene therapy solutions, announced today that the final Asset Purchase Agreement, as amended, has been executed and the transfer of the assets of SG Austria Pte. Ltd. to Nuvilex has begun.

Back to news